Details
Stereochemistry | MIXED |
Molecular Formula | C30H32N2O14S5 |
Molecular Weight | 804.905 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C(CC(C1=CC=CC=C1)S(O)(=O)=O)NC2=CC=C(C=C2)S(=O)(=O)C3=CC=C(NC(CC(C4=CC=CC=C4)S(O)(=O)=O)S(O)(=O)=O)C=C3
InChI
InChIKey=HCCUQCPVNVAHMV-UHFFFAOYSA-N
InChI=1S/C30H32N2O14S5/c33-47(34,25-15-11-23(12-16-25)31-29(50(41,42)43)19-27(48(35,36)37)21-7-3-1-4-8-21)26-17-13-24(14-18-26)32-30(51(44,45)46)20-28(49(38,39)40)22-9-5-2-6-10-22/h1-18,27-32H,19-20H2,(H,35,36,37)(H,38,39,40)(H,41,42,43)(H,44,45,46)
Solasulfone (sulphetrone) was used in drug therapy of leprosy. It was also used in a chemotherapy of pulmonary tuberculosis. Sulphetrone has a low toxicity and an antituberculous efficiency approaching that of its parent compound, diaminodiphenylsulphone; it is also curative in infections due to beta-haemolytic streptococci.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13199244
Male rabbits: Suspension or solution by stomach tube or parenterally, in dose of 0.5 g/kg
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8AZ283GK93
Created by
admin on Sat Dec 16 14:26:44 GMT 2023 , Edited by admin on Sat Dec 16 14:26:44 GMT 2023
|
PRIMARY | |||
|
8627
Created by
admin on Sat Dec 16 14:26:44 GMT 2023 , Edited by admin on Sat Dec 16 14:26:44 GMT 2023
|
PRIMARY | |||
|
DTXSID50861789
Created by
admin on Sat Dec 16 14:26:44 GMT 2023 , Edited by admin on Sat Dec 16 14:26:44 GMT 2023
|
PRIMARY | |||
|
118-84-3
Created by
admin on Sat Dec 16 14:26:44 GMT 2023 , Edited by admin on Sat Dec 16 14:26:44 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD